Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.18 USD | +1.95% | +1.21% | -24.00% |
May. 15 | Earnings Flash (MRKR) MARKER THERAPEUTICS Reports Q1 Revenue $1.2M | MT |
Apr. 30 | Ladenburg Thalmann Starts Marker Therapeutics With Buy Rating, $11 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.00% | 36.55M | |
+33.02% | 50.85B | |
+0.09% | 42.82B | |
+49.62% | 42.03B | |
-4.96% | 29.55B | |
+10.92% | 26.11B | |
-22.01% | 19.13B | |
+8.51% | 13.05B | |
+27.68% | 12.16B | |
+24.50% | 12.08B |
- Stock Market
- Equities
- MRKR Stock
- News Marker Therapeutics, Inc.
- Insider Trends: 90-Day Buying Trend Extended with Insider Purchase of Marker Therapeutics Stock